
The system
Forbion Raises Record $2.6 Billion for Life Sciences Funds
Forbion has secured $2.6 billion across two new venture funds.
Every Medical Research story tagged Biotech and venture funding.

Forbion has secured $2.6 billion across two new venture funds.

Shionogi has agreed to acquire biotech firm IntraBio for $2 billion in cash, gaining the marketed rare disease therapy Aqneursa.

Infectious disease biotech Invivyd has appointed board chairman Marc Elia as its new CEO.